Osaic Holdings
PVLA

Osaic Holdings’s Palvella Therapeutics PVLA Stock Holding History

Osaic Holdings’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9K Buy
91
+71
+355% +$8.62K ﹤0.01% 6413
2026
Q1 		$2.49K Buy
20
+18
+900% +$1.88K ﹤0.01% 6968
2025
Q4 		$209 Sell
2
-12
-86% -$1.02K ﹤0.01% 7575
2025
Q3 		$878 Buy
+14
New +$624 ﹤0.01% 7404
2025
Q1 		– Sell
-7
Closed -$84 – 7782
2024
Q4 		$84 Hold
7
– – ﹤0.01% 7260
2024
Q3 		$116 Hold
7
– – ﹤0.01% 7234
2024
Q2 		$69 Buy
7
+1
+17% +$11 ﹤0.01% 7284
2024
Q1 		$95 Hold
6
– – ﹤0.01% 7041
2023
Q4 		$94 Hold
6
– – ﹤0.01% 7115
2023
Q3 		$154 Hold
6
– – ﹤0.01% 7187
2023
Q2 		$85 Hold
6
– – ﹤0.01% 7299
2023
Q1 		$504 Hold
6
– – ﹤0.01% 7128
2022
Q4 		$1K Sell
6
-25
-81% -$2.01K ﹤0.01% 6997
2022
Q3 		$3K Hold
31
– – ﹤0.01% 6687
2022
Q2 		$5K Hold
31
– – ﹤0.01% 6513
2022
Q1 		$8K Hold
31
– – ﹤0.01% 6288
2021
Q4 		$10K Buy
31
+6
+24% +$1.92K ﹤0.01% 6266
2021
Q3 		$10K Hold
25
– – ﹤0.01% 6214
2021
Q2 		$8K Buy
+25
New +$5.48K ﹤0.01% 6219
2020
Q4 		– Sell
-8
Closed -$1K – 6615
2020
Q3 		$1K Hold
8
– – ﹤0.01% 6097
2020
Q2 		$2K Hold
8
– – ﹤0.01% 5843
2020
Q1 		$1K Buy
+8
New +$2.02K ﹤0.01% 5950

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Osaic Holdings's PVLA Position: Q2 2026 in Review

Osaic Holdings increased its Palvella Therapeutics (PVLA) stake by 355% in Q2 2026, buying an estimated $8.62K and bringing the position to 91 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6413.

Osaic Holdings first reported a position in PVLA in Q1 2020 and has held it in 22 quarters since. 196 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Osaic Holdings held 91 shares of Palvella Therapeutics worth $13.9K as of Q2 2026.
  • Osaic Holdings bought 71 Palvella Therapeutics shares in Q2 2026, an estimated $8.62K.
  • Palvella Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6413 holding.
  • Osaic Holdings first reported a position in Palvella Therapeutics in Q1 2020 and has held it in 22 quarters since.
  • 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.